medigraphic.com

2011, Número 3

<< Anterior Siguiente >>

Rev Med Inst Mex Seguro Soc 2011; 49 (3)


Insuficiencia respiratoria pulmonar aguda y transfusión

Rodríguez-Moyado H

Idioma: Español
Referencias bibliográficas: 46
Paginas: 273-280
Archivo PDF: 55.69 Kb.


RESUMEN

La insuficiencia respiratoria aguda es una complicación frecuente en pacientes críticos. La Food and Drug Administration la identifica en los primeros lugares de causa de muerte por transfusión. La transfusión se puede manifestar como síndrome de insuficiencia respiratoria pulmonar aguda (SIRPA), sobrecarga circulatoria por transfusión (síndrome TACO) y síndrome de insuficiencia respiratoria aguda secundaria a transfusión (TRALI), en los cuales se observan disnea de instalación súbita, infiltrados pulmonares bilaterales (en la radiografía de tórax) e hipoxia de 90 % o menor. La producción del TRALI se ha atribuido a anticuerpos antileucocitos contenidos en el plasma del componente transfundido, específicos contra los antígenos leucocitarios de los pacientes. Es muy probable que el blanco de la acción nociva de los anticuerpos antileucocitos y de las sustancias en el plasma almacenado sean las células endoteliales de los capilares pulmonares, las cuales están afectadas por un estado inflamatorio previo; esto último ha sido planteado como mecanismo de producción, semejante al fenómeno de Sanarelli– Shwartzman. La prevención de estos síndromes está en evitar la transfusión insuficientemente fundamentada en pacientes críticos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Garber BG, Hebert PC, Yelle JD, Hoddre RV, McGowan J. Adult respitarory distress syndrome. a systematic overview of incidence and risk factors. Critical Care Med 1996;24(4):687-695.

  2. Popovsky MA. Transfusion-related acute lung injury and transfusion associated circulatory overload. ISBT Science Series 2006;1(1):107-111.

  3. Popovsky MA, Moore SB. Diagnostic and pathogenic consideration in transfusion-related acute lung injury. Transfusion 1985;25(6):573-577.

  4. Fauci AS, Braunwald E, Kasper DL, Hauser SL, Dan L. Longo DL, et al. Harrison´s Principles of internal medicine. Tenth edition. Auckland: McGraw Hill; 1983. p. 1592- 1598.

  5. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967;2(7511):319- 323.

  6. Shorr AF, Duh MS, Kelly KM, Kollef MH, CRITT Study Group. Red blood cell transfusion and ventilator-associated pneumonia. A potential link? Crit Care Med 2004;2(3):666-674.

  7. Wallis JP, Lubenko A. Wells AW, Chapman CE. Single hospital experience of TRALI. Transfusion 2003;43(8): 1053-1059.

  8. Wintrobe´s Clinical hematology. Ninth edition. Philadelphia- London: Lea and Febiger; 1993, p704.

  9. Bouros D, Nicholson AC, Polychronopoulos V, du Bois RM. Acute interstitial pneumonia. Eur Resp J 2000;15 (2):412.

  10. Gruson D, Hilbert G, Portel L, Boiron JM, et al. Severe respiratory failure requiring ICU admission in bone marrow transplant recipients. Eur Respir J 1999;13(4):883-887.

  11. Kleinman S, Cauldfield T, Chan P, Davenport R, McFarland J, et al. Toward and understanding of transfusion –related acute lung injury: statement of a concensus panel. Transfusion 2004;44(12):1774-1789.

  12. Goldman M, Welbert KE, Arnold DM, Freedman J, et al. Proceedings of a Consensus Conference: towards an understanding of TRALI. Transfus Med Rev 2005;19(1):2- 31.

  13. Honing CL, Bove JR. Transfusion associated fatalities review of bureau of biologic reports 1976-1978. Transfusion 1980;20(6):653-661.

  14. Sazama K. Transfusion 29. Abstract Suppl. AABB’s 42nd Anual Meet, Nueva Orleans. Lo. Oct 21-26, 1989 S121:365.

  15. Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman M. Proceedings of a concensus conference: towards an understanding of TRALI. Transfusion Med Rev 2005;19(1):2-31.

  16. Bux J. Transfusion-related acute lung injury (TRALI): a serius adverse event of blood transfusion. Vox Sang 2005;8 9(1):1-10.

  17. Garber BG, Hebert PC, Yelle JD, Hodder RV, Mc Gowan J. Adult respiratory distress syndrome: A systematic overview of incidence and risk factors. Crit Care Med 1996;24(4):687-695.

  18. Fiebig EW, Wu AHB, Krombach J, Tang J, et al. Transfusion- related acute lung injury and transfusion –associated circulatory overload : Mutually exclusive or coexisting entities? Transfusion 2007;47(1):171-172.

  19. Popvsky MA, Taswell HE. Circulatory overload: An under- diagnosed consequence of transfusion. Transfusion 1985;25(5 S96):469. [Abstract].

  20. Loria A, Sánchez-Medal L, Kauffer N, Quintanar E. Relation ship between body hemotocrit and venous hematocrito in normal, splenomegalic, and anemic states. J Lab Clin Med 1962;60:396-408.

  21. Rana R, Fernández-Pérez ER, Khan SA, Rana S, Winters JL, Lesnick TG, et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Tranfusion 2006;46(9):1478-1483.

  22. Silliman CC, Boshkow L, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podiosky L, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003;101(2):454-462.

  23. Eder AF, Herron R, Strupp A, Dy B, Notari EP, Chambers LA, et al. Transfusion – related acute lung injury surveillance (2003-2005) and the potencial impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007;47(4):599-607.

  24. Fadeyi EA, Muniz M de los A, Wayne AS, Klein HG, Leitman SF, Stroncek DF. The transfusion of neutrophil –specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions. Transfusion 2007;47(3):545-550.

  25. Fadeyi EA, Adams S, Sheldon S, Leitman SF, Wesley R, Kleing HG, et al. A preliminary comparisoin of the prevalence of transfusion reactions in recipients of platelet components from donors with and without human leucocyte antigen antibodies. Vox Sang 2008;94(4):324-328.

  26. Bux J, Junk KD, Kauth T, Müller-Ekhardt C. Serological and clinical aspects of granulocyte antibodies leading to alloimmune neonatal neutropenia. Transfus Med 1992;2(2):143-149.

  27. Van Buren NL, Stroncek DF, Clay ME, McCollough J, Dalmasso AP. Transfusion-related acute lung injury caused by and NB2 granulocyte-specific antiboy in a patient with thrombotic thrombocytopenic purpura. Transfusion 1990;30(1):42-45.

  28. Fusco L. Blood management in the face of TRALI. AABB News 2008;20:6-10.

  29. Stainsby D, Jones H, Wells AW, Gibson B, Cohen H. on behalf of the Serious hazards of Transfusion (SHOT) Steering Group. Adverse outcomes of blood transfusion of children: analysis of UK reports to the Serious Hazards of Transfusion Scheme. Br J Haematol 2008;141:73-79

  30. Stroncek DE, Klein HG. Heavy breathing in the blood bank: is it transfusion-related lung injury, our anxiety or both? Transfusion 2007;47(4): 559-562.

  31. Yasin K, Furuta RA, Matsumaya N, Fukomory, et al. Possible involvement of Heparin binding protein in transfusiónrelated acute lung injury. Trasnfusion 2008;48(5):978- 987.

  32. Vamvakas EF, Blajchman MA. Transfusion-related inmmunomodulation (TRIM): An Update. Blood Rev 2007;21(6): 327-348.

  33. Davis A,. Mandal R, Johnson M, Makar R, Stowell C, Dzik S. A touch of TRALI. Transfusion 2008;48(3):541-545.

  34. Maslanka K, Michur H, Zupanska B, Uhrynowska M, Nowak J. Leucocyte antibodies in blood donors a look back on recipients of their blood components. Vox Sang 2007;92(3):247-249.

  35. Toy P, Hollis-Perry KM, Jun J, Nakagawa M. Recipients of blood from a donor with multiple antibodies: a lookback stody of transfusion-related acute lung injury. Transfusion 2004;44(12):1983-1988.

  36. Win N, Ranasinghe E, Lucas G. Transfusion-related acutte lung injury: A 5 year look- back. Transfus Med 2002;12(6): 387-389.

  37. Middelburg RA, van Stein D, Briët E, van der Bom JG. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion 2008;48(10): 2167-2176.

  38. Overweg J. Engelfrield CP. Citotoxic leucocyte isoatibodies formed during the first pregnancy. Vox Sang 1969;16(2):97.

  39. Walker RH. Serum analysis. En: Fawcet KJ, Hackel E, Mallory D. editor. HLA techniques for blood bankers. Arlington, VA: Am Assoc Blood Banks; 1984. p. 105-134

  40. Corwin HL, Krantz SB. Anemia of the critically ill: acute anemia of chronic disease. Crit Care Med 2000;28(8): 3098-3099.

  41. Win N, Lucas G, Navarrete C, Ouwehand WH. Implicated blood donor in TRALI cases. Transfus Med 2000;10(Suppl I):33-36.

  42. Silliman CC, Kelher M. The role of endothelial activation in the pathogenesis of transfusion related acute lung injury. Transfusion 2005;45(2 Suppl):109S-116 S.

  43. Selye H. Trombohemorrhagic phenomena. Springfield, Illinois, USA: Charles C. Thomas Publisher; 1966. p. 3, 15, 47, 48, 236.

  44. Brittingham TE, Chaplin Hjr. Febrile transfusion reaction caused by sensitivity to donor leucocytes and platelets. JAMA 1957;165(7):819.

  45. Renaudier P, Vo MaiLegras JP. Epidemiology of transfusionrelated acute lung injury in e-FIT the French Hemovigilance Network. Vox Sang 2007;93(Suppl 2):37(4A -S16-4).

  46. Wendel S, Biiagini S, Trigo F, et al. Measures to prevent TRALI (International Forum) Vox Sang 2007;92(3):187-279.




2020     |     www.medigraphic.com